Endocrine: Diabetes & Insulin Management

Diabetes & Insulin Management: Mastering NAPLEX Essentials

Achieve NAPLEX success with diabetes and insulin management concepts, supported by free flashcards and active recall practice. This lesson covers insulin types and pharmacokinetics, blood glucose monitoring and targets, medication therapy management for type 1 and type 2 diabetes, and critical adverse effects including hypoglycemia recognition and management—essential knowledge for safe, evidence-based patient care.

---

Welcome to Diabetes & Insulin Management 💉

Diabetes mellitus affects over 37 million Americans, making it one of the most commonly encountered conditions in pharmacy practice. As a future pharmacist, you'll counsel patients daily on insulin administration, interpret A1C values, prevent medication errors, and recognize dangerous complications. This lesson provides the high-yield content you need to excel on the NAPLEX while building clinical competence for real-world practice.

---

Core Concepts

🔬 Pathophysiology Overview

Type 1 Diabetes (T1DM): Autoimmune destruction of pancreatic beta cells → absolute insulin deficiency. Patients require exogenous insulin for survival. Typically diagnosed in youth but can occur at any age (LADA = latent autoimmune diabetes in adults).

Type 2 Diabetes (T2DM): Insulin resistance + relative insulin deficiency. Progressive beta-cell dysfunction over time. May eventually require insulin therapy. Accounts for ~90-95% of all diabetes cases.

Key Distinction for NAPLEX: Type 1 = no insulin production (always needs insulin). Type 2 = insulin resistance (may or may not need insulin).

💡 Clinical Pearl: Even in T2DM, during acute illness, surgery, or pregnancy, temporary insulin therapy may be necessary regardless of usual management strategy.

---

💊 Insulin Classification & Pharmacokinetics

Insulins are categorized by onset, peak, and duration of action. Understanding these parameters is critical for matching insulin to patient needs and preventing hypoglycemia.

Insulin Type	Generic Names	Onset	Peak	Duration	Clinical Use
Rapid-Acting	Lispro, Aspart, Glulisine	5-15 min	1-2 hrs	4-6 hrs	Bolus dosing with meals; correction doses
Short-Acting	Regular (human insulin)	30 min	2-3 hrs	6-10 hrs	Meal coverage (dose 30 min before); IV use in DKA
Intermediate-Acting	NPH (neutral protamine Hagedorn)	1-2 hrs	4-12 hrs	18-24 hrs	Basal coverage; often twice daily dosing
Long-Acting	Glargine (U-100, U-300), Detemir	1-2 hrs	Minimal/none	20-24 hrs	Once/twice daily basal coverage
Ultra-Long-Acting	Degludec, Glargine U-300	1-2 hrs	None	≥42 hrs	Once daily basal; more stable levels
Premixed	70/30, 75/25, 50/50	Varies	Dual	10-24 hrs	Fixed-ratio combinations; less flexibility

🧠 Mnemonic for Rapid-Acting Insulins: "LAG before meals" (Lispro, Aspart, Glulisine) - but actually NO lag, they work fast!

⚠️ NAPLEX Alert: NPH is the ONLY cloudy insulin. All others are clear solutions. If you see "cloudy insulin" on the exam, think NPH. Must be gently rolled (not shaken) to resuspend.

---

📊 Basal-Bolus Insulin Regimen

The physiologic insulin replacement strategy mimics normal pancreatic function:

PHYSIOLOGIC INSULIN PATTERN

    ┌─────────────────────────────────────────────┐
    │  Insulin Levels Throughout the Day          │
    └─────────────────────────────────────────────┘

  High│     ↗️ Bolus    ↗️ Bolus    ↗️ Bolus
      │    ╱ ╲        ╱ ╲        ╱ ╲
      │   ╱   ╲      ╱   ╲      ╱   ╲
  Med │  ╱     ╲    ╱     ╲    ╱     ╲
      │ ╱       ╲  ╱       ╲  ╱       ╲
      │╱         ╲╱         ╲╱         ╲
  Low ├──────────────────────────────────────────
      └──────────────────────────────────────────
      │  Basal (steady background insulin)        │
      └──────────────────────────────────────────
       7am      12pm      6pm      11pm
      Breakfast  Lunch    Dinner   Bedtime

Basal Insulin (40-50% of total daily dose):

• Provides steady background insulin
• Suppresses hepatic glucose production
• Long-acting: glargine, detemir, degludec
• Dose adjustment based on fasting glucose

Bolus Insulin (50-60% of total daily dose):

• Covers carbohydrate intake at meals
• Provides correction for high blood glucose
• Rapid-acting: lispro, aspart, glulisine
• Dose adjustment based on premeal and postprandial glucose

💡 Clinical Application: If fasting glucose is elevated → increase basal insulin. If postprandial glucose is elevated → increase bolus insulin or adjust carb ratio.

---

🎯 Blood Glucose Targets & A1C Goals

Parameter	Target Range	Notes
Fasting/Preprandial	80-130 mg/dL	Check before meals; reflects basal insulin adequacy
Postprandial (2hr)	<180 mg/dL	Peak occurs 1-2 hours after meal start; reflects bolus adequacy
Bedtime	100-140 mg/dL	Prevents nocturnal hypoglycemia
A1C (general)	<7%	Average glucose ~154 mg/dL; reduces microvascular complications
A1C (individualized)	6.5-8%	Depends on hypoglycemia risk, life expectancy, comorbidities

A1C Conversion: Reflects average glucose over 2-3 months (RBC lifespan ~120 days).

🧮 eAG Formula: eAG (mg/dL) = 28.7 × A1C - 46.7

Example: A1C 7% → eAG = 28.7(7) - 46.7 = 154 mg/dL

⚠️ A1C Limitations:

• Falsely low: hemolytic anemia, blood loss, sickle cell disease
• Falsely high: iron deficiency anemia, splenectomy, reduced RBC turnover
• Cannot use in pregnancy (glucose changes too rapidly)

🤔 Did You Know? Each 1% reduction in A1C decreases microvascular complications by ~37%. Even small improvements matter!

---

📐 Insulin Dosing Calculations

Total Daily Dose (TDD) Estimation

Weight-based approach:

• Type 1 DM: 0.5-0.6 units/kg/day (initial)
• Type 2 DM: 0.3-0.5 units/kg/day (insulin-naive)
• Type 2 DM: 0.5-1.5 units/kg/day (insulin-resistant)

Distribution:

• Basal: 50% of TDD (long-acting insulin)
• Bolus: 50% of TDD divided among 3 meals

Insulin-to-Carbohydrate Ratio (I:C)

Determines how much rapid-acting insulin to give per grams of carbohydrate consumed.

Formula: 500 Rule → 500 ÷ TDD = grams of carb covered by 1 unit

Example: TDD = 50 units → 500 ÷ 50 = 10 grams carb per 1 unit insulin (1:10 ratio)

If patient eats 60g carbs → 60 ÷ 10 = 6 units rapid-acting insulin

Correction Factor (Insulin Sensitivity Factor)

Determines how much 1 unit of rapid-acting insulin will lower blood glucose.

Formula: 1800 Rule → 1800 ÷ TDD = mg/dL drop per 1 unit

Example: TDD = 50 units → 1800 ÷ 50 = 36 mg/dL drop per unit

If current BG is 220 mg/dL and target is 120 mg/dL:

• Correction needed: 220 - 120 = 100 mg/dL
• Insulin units: 100 ÷ 36 = 2.8 units (round to 3 units)

💡 Total Meal Dose = Carb coverage + Correction dose

---

🚨 Hypoglycemia: Recognition & Management

Definition: Blood glucose <70 mg/dL

Clinical Presentation:

• Autonomic symptoms (BG 50-70): tremor, palpitations, sweating, hunger, anxiety
• Neuroglycopenic symptoms (BG <50): confusion, difficulty concentrating, slurred speech, vision changes, seizures, loss of consciousness

Severe Hypoglycemia (unconscious, unable to swallow):

• Glucagon 1 mg IM/SubQ (can repeat after 15 min if needed)
• Dextrose 50% IV (10-25 grams) in hospital setting

⚠️ Never give oral carbs to unconscious patients → aspiration risk!

Hypoglycemia Unawareness: Loss of autonomic warning symptoms. Common with:

• Long-standing diabetes
• Frequent hypoglycemic episodes
• Beta-blocker use (masks symptoms)
• Tight glycemic control

🧠 Strategy: Relax A1C goals slightly (e.g., 7.5-8%) to reduce hypoglycemia frequency and potentially restore awareness.

---

💉 Insulin Administration Techniques

Injection Sites (SubQ absorption rates):

1. Abdomen (fastest) - preferred for rapid-acting
2. Arms (medium) - deltoid area
3. Thighs (slower) - lateral aspects
4. Buttocks (slowest) - upper outer quadrant

Rotation Strategy: Rotate within the same anatomic region (e.g., different quadrants of abdomen) to maintain consistent absorption. Don't switch between regions day-to-day.

Injection Technique:

• Use 45-90° angle depending on needle length and body composition
• Pinch skin for thin patients with longer needles
• Inject, count to 10, then withdraw (prevents leakage)
• No need to aspirate (SubQ injection)
• Room temperature insulin (refrigerated insulin may cause discomfort)

Needle Length: 4mm (most patients), 6mm, 8mm (rarely needed)

💡 Lipohypertrophy Prevention: Rotate injection sites within region. Lipohypertrophy causes unpredictable absorption and poor glycemic control.

---

🔄 Insulin Storage & Stability

Storage Condition	Duration	Temperature
Unopened vials/pens	Until expiration date	36-46°F (2-8°C) refrigerated
Opened vials (in use)	28 days (most insulins)	Room temp <86°F (30°C)
Opened pens (in use)	7-42 days (varies by product)	Room temp <86°F (30°C)

⚠️ Discard insulin if:

• Frozen (crystals form, denatures protein)
• Exposed to excessive heat (>86°F)
• Clumping, discoloration, or particles visible (except NPH cloudiness)
• Past expiration or beyond in-use timeframe

💡 Patient Counseling Point: "Write the date you opened it on the vial/pen. Discard after 28 days even if insulin remains."

---

🩺 Continuous Glucose Monitoring (CGM)

Time in Range (TIR): Percentage of time glucose is 70-180 mg/dL

• Goal: >70% TIR
• Correlates with A1C and complication risk
• More informative than A1C alone (shows variability)

Glucose Management Indicator (GMI): CGM-derived estimate of A1C based on average sensor glucose over 14 days.

Advantages over fingerstick testing:

• Real-time continuous data
• Alerts for high/low glucose
• Reveals patterns (dawn phenomenon, postprandial spikes)
• No fingersticks (or minimal for calibration)

⚠️ Lag Time: CGM measures interstitial fluid glucose, which lags blood glucose by 5-10 minutes. During rapidly changing glucose, fingerstick may be more accurate.

---

🔄 Sick Day Management

During illness (infection, fever, vomiting, stress), glucose typically rises due to counter-regulatory hormones.

Key Principles:

1. Never stop basal insulin (T1DM → DKA risk)
2. Check BG every 2-4 hours
3. Check ketones if BG >250 mg/dL
4. Maintain hydration (8 oz fluid hourly)
5. Use correction doses of rapid-acting insulin per sliding scale
6. Contact provider if persistent hyperglycemia, moderate/large ketones, vomiting

💡 If unable to eat: Still give basal insulin. May reduce bolus insulin but don't eliminate it. Switch to liquid carbs (juice, broth, popsicles).

---

🧪 Type 2 Diabetes Medication Therapy

While insulin is critical, understanding when to use it in T2DM vs. other agents is NAPLEX-relevant.

First-Line: Metformin (unless contraindicated)

• Mechanism: ↓ hepatic glucose production, ↑ insulin sensitivity
• No hypoglycemia risk (as monotherapy)
• Weight neutral or modest weight loss
• GI side effects common (start low, titrate slow, take with food)

When to Add/Switch to Insulin in T2DM:

1. A1C ≥10% or BG >300 mg/dL with symptoms (consider starting insulin)
2. Inadequate control on maximum oral/injectable non-insulin agents
3. Contraindications to other medications (renal/hepatic impairment)
4. Acute illness, surgery, hospitalization (temporary)
5. Pregnancy (insulin is safe)

GLP-1 Receptor Agonists (e.g., dulaglutide, semaglutide):

• ↑ insulin secretion (glucose-dependent)
• ↓ glucagon, ↓ appetite, delays gastric emptying
• Cardiovascular benefit (preferred in ASCVD)
• Weight loss
• Injectable (weekly or daily)

SGLT2 Inhibitors (e.g., empagliflozin, dapagliflozin):

• ↑ renal glucose excretion
• Cardiovascular and renal benefit (preferred in HF, CKD)
• Weight loss, ↓ BP
• Risk: genital mycotic infections, DKA (rare)

🧠 NAPLEX Strategy: Know when insulin is absolutely required (T1DM, DKA, HHS, pregnancy with inadequate control) vs. when it's one option among many (T2DM).

---

Clinical Examples

Example 1: Calculating Total Daily Insulin Dose

Case: A 70 kg patient with newly diagnosed T1DM needs insulin therapy initiation.

Solution:

Step	Calculation	Result
1. Calculate TDD	0.5 units/kg × 70 kg	35 units/day
2. Determine basal dose	50% × 35 units	17.5 units → 18 units once daily
3. Determine bolus dose	50% × 35 units = 17.5 units	Divide among 3 meals: 6 units each

Prescription:

• Basal: Insulin glargine 18 units SubQ once daily at bedtime
• Bolus: Insulin lispro 6 units SubQ before each meal (breakfast, lunch, dinner)

💡 Clinical Note: This is a starting point. Titrate based on self-monitoring blood glucose (SMBG) data. Adjust basal dose based on fasting glucose. Adjust bolus doses based on premeal/postprandial readings.

---

Example 2: Insulin-to-Carb Ratio Calculation

Case: A patient on 60 units TDD wants to eat 75 grams of carbohydrates at lunch. Current BG is 110 mg/dL (target 120 mg/dL). How much rapid-acting insulin should be administered?

Solution:

Step	Calculation	Result
1. Calculate I:C ratio	500 ÷ 60 TDD	8.3 grams carb per 1 unit (1:8 ratio)
2. Calculate carb coverage	75 g carbs ÷ 8	9.4 units → round to 9 units
3. Calculate correction	110 (current) - 120 (target) = -10	No correction needed (BG at target)
4. Total insulin dose	9 units + 0 units	9 units lispro SubQ

⚠️ Important: If BG was 200 mg/dL, you'd also calculate correction dose using 1800 rule and add it to the carb coverage dose.

---

Example 3: Treating Hypoglycemia

Case: A patient with T1DM reports feeling shaky, sweaty, and anxious. BG fingerstick shows 55 mg/dL. Patient is conscious and able to swallow. What do you recommend?

Solution:

Immediate Action - Rule of 15:

1. Give 15 grams fast-acting carbohydrate:

   • Option 1: 4 oz (½ cup) orange juice
   • Option 2: 4 glucose tablets
   • Option 3: 1 tablespoon honey

2. Wait 15 minutes (set a timer!)

3. Recheck BG:

   • If ≥70 mg/dL → Eat a snack with protein/complex carb (cheese & crackers, peanut butter on bread)
   • If still <70 mg/dL → Repeat 15g carb treatment

4. Investigate cause:

   • Skipped/delayed meal?
   • Increased physical activity?
   • Too much insulin?
   • Alcohol consumption?

Prevention Counseling:

• Always carry fast-acting carbs
• Check BG before driving
• Wear medical ID bracelet
• Educate family on glucagon administration
• Adjust insulin for planned exercise

💡 Pharmacy Role: Ensure patient has glucagon emergency kit prescribed and family members are trained on use.

---

Example 4: Adjusting Basal vs. Bolus Insulin

Case: A patient on glargine 30 units at bedtime and lispro 8 units before each meal presents with the following SMBG pattern over 3 days:

Time	Day 1	Day 2	Day 3
Fasting (AM)	165	170	158
Pre-lunch	210	220	205
Pre-dinner	190	185	195
Bedtime	180	175	185

Analysis:

• Fasting glucose elevated (target 80-130) → Basal insulin insufficient
• All readings elevated → Suggests inadequate basal AND possible bolus adjustment needed

Recommendation:

1. Increase basal insulin first: Glargine 30 units → 33 units (10% increase)
2. Monitor fasting glucose for 3 days
3. If fasting improves but daytime readings remain high → consider increasing breakfast bolus
4. Ensure patient is taking lispro at correct time (immediately before meals, not after)

💡 Titration Principle: Adjust ONE insulin at a time. Fix basal first (fasting glucose), then optimize bolus (postprandial).

---

⚠️ Common Mistakes

1. Confusing Insulin Types

❌ Mistake: Prescribing NPH for once-daily basal coverage ✅ Correction: NPH requires twice-daily dosing due to 18-24 hour duration and pronounced peak. Use glargine/detemir/degludec for once-daily basal.

2. Incorrect Insulin Timing

❌ Mistake: Administering rapid-acting insulin 30 minutes before meal ✅ Correction: Rapid-acting (lispro, aspart, glulisine) should be given immediately before or with the first bite of food (onset 5-15 min). Regular insulin requires 30-minute lead time.

3. Mixing Insulins Incorrectly

❌ Mistake: Mixing glargine with other insulins in same syringe ✅ Correction: Never mix glargine or detemir with other insulins (acidic pH causes precipitation). Only NPH and regular can be mixed (draw clear before cloudy: "Clear skies before cloudy storms").

4. Stopping Insulin During Illness

❌ Mistake: Patient stops all insulin because "I'm not eating" ✅ Correction: Never stop basal insulin in T1DM (DKA risk). May need to reduce bolus if not eating, but illness often increases insulin requirements due to stress hormones.

5. Treating Hypoglycemia with Protein/Fat

❌ Mistake: Giving peanut butter crackers, milk, or chocolate for acute hypoglycemia ✅ Correction: Use pure carbohydrate (juice, glucose tablets, sugar) for immediate treatment. Protein/fat slow absorption. Save mixed snacks for after BG normalizes to prevent recurrence.

6. Incorrect Dose Adjustments

❌ Mistake: Making large insulin dose changes (e.g., doubling dose) based on single BG reading ✅ Correction: Adjust by 10-20% (or 2-4 units) at a time. Base decisions on patterns over 3+ days, not single values. Assess for causes of out-of-range readings (diet, activity, illness, medication adherence).

7. Ignoring Injection Site Rotation

❌ Mistake: Always injecting in same exact spot → lipohypertrophy ✅ Correction: Rotate sites within anatomic region. Check for lumps/firmness at injection sites. Lipohypertrophy causes erratic absorption and poor control.

8. Misunderstanding A1C in Special Populations

❌ Mistake: Using A1C as sole measure in patient with hemolytic anemia ✅ Correction: A1C unreliable with altered RBC lifespan. Use fructosamine or glycated albumin instead. Also unreliable in pregnancy (use daily SMBG).

---

💡 Key Takeaways

✅ Insulin classification: Rapid (meal coverage), short (regular insulin), intermediate (NPH), long/ultra-long (basal)

✅ Basal-bolus regimen: Mimics physiologic insulin; 50% basal (controls fasting) + 50% bolus (controls postprandial)

✅ Glycemic targets: Fasting 80-130 mg/dL, postprandial <180 mg/dL, A1C <7% (individualize!)

✅ Dosing calculations:

• TDD: 0.5-0.6 units/kg (T1DM), 0.3-1.5 units/kg (T2DM)
• I:C ratio: 500 ÷ TDD = grams carb per 1 unit
• Correction factor: 1800 ÷ TDD = mg/dL drop per 1 unit

✅ Hypoglycemia treatment: Rule of 15 (15g carb → wait 15 min → recheck). Glucagon 1 mg IM/SubQ for severe cases.

✅ Administration: SubQ injection, rotate sites within region, room temperature insulin, count to 10 before withdrawing needle

✅ Storage: Unopened (refrigerate until expiration), opened (room temp for 28 days for most products)

✅ NPH is cloudy (only one!), must be resuspended. Never mix long-acting insulins.

✅ Sick day rules: Never stop basal insulin (T1DM), check BG and ketones frequently, stay hydrated

✅ Insulin in T2DM: Consider when A1C ≥10%, max oral therapy inadequate, contraindications exist, or acute illness/pregnancy

✅ Adjust insulin methodically: One type at a time, 10-20% changes, based on 3+ day patterns

---

---

📚 Further Study

1. American Diabetes Association Standards of Care: https://diabetesjournals.org/care/issue/47/Supplement_1 - Annual updates on evidence-based guidelines for diabetes management

2. FDA Insulin Product Information: https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/information-about-insulin - Official guidance on insulin products, biosimilars, and safety

3. NAPLEX Competency Statements (Area 1.1 - Diabetes): https://nabp.pharmacy/programs/naplex/naplex-competency-statements/ - Review specific testable objectives for diabetes and endocrine disorders

---

You've completed Diabetes & Insulin Management! 🎉 Master these high-yield concepts with spaced repetition practice using the free flashcards, and you'll be well-prepared for NAPLEX success and confident clinical practice. Next, test your knowledge with the practice questions below!